APA (7th ed.) Citation

M, P., A, C., LS, L., NBB, M., & CJ, D. (2021). Melanoma-associated glycosyltransferase GCNT2 as an emerging biomarker and therapeutic target. The British journal of dermatology, 185(2), 294. https://doi.org/10.1111/bjd.19891

Chicago Style (17th ed.) Citation

M, Perez, Chakraborty A, Lau LS, Mohammed NBB, and Dimitroff CJ. "Melanoma-associated Glycosyltransferase GCNT2 as an Emerging Biomarker and Therapeutic Target." The British Journal of Dermatology 185, no. 2 (2021): 294. https://doi.org/10.1111/bjd.19891.

MLA (9th ed.) Citation

M, Perez, et al. "Melanoma-associated Glycosyltransferase GCNT2 as an Emerging Biomarker and Therapeutic Target." The British Journal of Dermatology, vol. 185, no. 2, 2021, p. 294, https://doi.org/10.1111/bjd.19891.